ReviewMolecular psychiatry2019

PPARγ agonists: potential treatment for autism spectrum disorder by inhibiting the canonical WNT/β-catenin pathway.

Alexandre Vallée et al.PubMed ↗Publisher ↗

No numbers read from the abstract.